Funded Startups in La Jolla
Across the 37 most recent La Jolla–listed rounds, the largest disclosed amount is Palomar’s $450M (2026-02-02).
Across the 37 most recent La Jolla–listed rounds, the largest disclosed amount is Palomar’s $450M (2026-02-02). That figure dwarfs the next-largest disclosed rounds in this set, including Janux Therapeutics at $350M (2024-12-03) and NeoVolta at $250M (2024-11-13), while several other disclosed deals cluster well below $100M (for example CalciMedica at $49M on 2026-06-24 and Artelo Biosciences at $11M on 2026-03-27). The list is also time-tight at the top: multiple rounds fall in 2026 with CalciMedica (2026-06-24, $49M), Palomar (2026-02-02, $450M), and Equillium (2026-03-13, $35M), before earlier biotech-heavy entries extend back to Dare Bioscience on 2020-09-21 ($900K).
Sector and stage mix skew toward life sciences: Biotechnology appears in at least 15 of the 37 rows, and “Series Unknown” is the most common labeled stage (at least 22 rows), alongside several “undisclosed” amounts (at least 4 rows). The smallest disclosed round is XNow’s $530K (2023-01-19), contrasting with larger disclosed rounds spanning consumer electronics (NeoVolta, $250M; 2024-11-13) and financial services (Palomar, $450M; 2026-02-02).
Most recent rounds
37 shownRelated listings
Frequently asked
What’s the largest disclosed round in this La Jolla list, and how separated is it from the rest?
Palomar’s $450M (2026-02-02) is the clear top disclosed amount, substantially above the next-largest disclosed rounds: Janux Therapeutics at $350M (2024-12-03) and NeoVolta at $250M (2024-11-13). Most other disclosed amounts shown are far lower, such as CalciMedica at $49M (2026-06-24) and Artelo Biosciences at $11M (2026-03-27).
Do any sectors appear disproportionately often across these 37 recent entries?
Biotechnology dominates, appearing in at least 15 of the 37 rows (e.g., CalciMedica 2026-06-24, Equillium 2026-03-13, and INmuneBIO 2024-09-13). Other categories show up, but none match that frequency in the displayed set (for example Financial Services appears in Palomar 2026-02-02 and Abacus as of 2026-04-28).
How much of the activity is concentrated near the top of the date range (latest quarters), based on the rows shown?
Several rounds cluster in 2026 among the most recent records: CalciMedica closed 2026-06-24 ($49M), Abacus is dated 2026-04-28 (undisclosed), and Equillium closed 2026-03-13 ($35M), with Palomar at 2026-02-02 ($450M). The overall window for the 37 rows runs from 2026-06-24 back to 2020-09-21 (Dare Bioscience, $900K).
Where do stage labels concentrate: how common are “Series Unknown” and missing/undisclosed amounts?
“Series Unknown” is the most frequent labeled stage (at least 22 of 37 rows), including CalciMedica (2026-06-24, $49M) and Artelo Biosciences (2026-03-27, $11M). Undisclosed amounts also recur: Abacus (2026-04-28), Oberon Fuels (2026-02-23), AlphaCore (2023-12-05), and Tentarix Biotherapeutics (2023-08-15) are labeled undisclosed in this excerpt.
Are there notable outliers at the small end or in sector mix compared with the largest disclosed deals?
The smallest disclosed amount is XNow at $530K (2023-01-19, Seed), which is much smaller than the top disclosed rounds such as Palomar’s $450M (2026-02-02). Sector mix also diverges from the life-sciences concentration at the top end: NeoVolta (Consumer Electronics) raised $250M on 2024-11-13, and Events.com (Advertising) raised $100M on 2024-09-12, sitting alongside the biotech-heavy entries.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.